These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 6743193)
21. [The effects of digitalis compounds on K(+)-induced relaxation in aortic rings]. Dorantes AL; Aldana I; Pastelín G; Escalante B Arch Inst Cardiol Mex; 1994; 64(6):511-5. PubMed ID: 7726685 [TBL] [Abstract][Full Text] [Related]
22. Activation of (Na+ + K+)-ATPase induces positive inotropy in intact mouse heart in vivo. Xu KY; Takimoto E; Fedarko NS Biochem Biophys Res Commun; 2006 Oct; 349(2):582-7. PubMed ID: 16949050 [TBL] [Abstract][Full Text] [Related]
23. Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins. Müller-Ehmsen J; Nickel J; Zobel C; Hirsch I; Bölck B; Brixius K; Schwinger RH Basic Res Cardiol; 2003 Mar; 98(2):90-6. PubMed ID: 12607130 [TBL] [Abstract][Full Text] [Related]
24. Novel therapeutic applications of cardiac glycosides. Prassas I; Diamandis EP Nat Rev Drug Discov; 2008 Nov; 7(11):926-35. PubMed ID: 18948999 [TBL] [Abstract][Full Text] [Related]
25. Myocardial mitogenic effect of erythropoietin through the activation of Na(+)-K(+)-ATPase activity. Sterin-Borda L; Wald M; Gutnisky A; Casanova M; Arana R; Borda E Acta Physiol Pharmacol Ther Latinoam; 1994; 44(1-2):1-10. PubMed ID: 7640398 [TBL] [Abstract][Full Text] [Related]
26. Potassium current and sodium pump involvement in the positive inotropy of cardiac muscle during hyperosmotic stress. Kasamaki Y; Guo AC; Shuba LM; Ogura T; McDonald TF Can J Cardiol; 1998 Feb; 14(2):285-94. PubMed ID: 9520866 [TBL] [Abstract][Full Text] [Related]
27. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition. Paula S; Tabet MR; Ball WJ Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774 [TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of novel sodium/potassium-ATPase inhibitors by virtual screening of a compound database. Stanton DT; Ankenbauer J; Rothgeb D; Draper M; Paula S Bioorg Med Chem; 2007 Sep; 15(18):6062-70. PubMed ID: 17618121 [TBL] [Abstract][Full Text] [Related]
29. Down-regulation of Na+ pump alpha 2 isoform in isoprenaline-induced cardiac hypertrophy in rat: evidence for increased receptor binding affinity but reduced inotropic potency of digoxin. Baek M; Weiss M J Pharmacol Exp Ther; 2005 May; 313(2):731-9. PubMed ID: 15644428 [TBL] [Abstract][Full Text] [Related]
30. Effect of quinidine on the inotropic effect of cardiac glycosides in isolated cardiac muscle. Hair TL; Taubert KA Proc West Pharmacol Soc; 1983; 26():313-6. PubMed ID: 6889359 [No Abstract] [Full Text] [Related]
31. [Inhibitory effects of 6 cardiac glycosides on sodium pump in sheep Purkinje fibers]. Han DY Zhongguo Yao Li Xue Bao; 1994 May; 15(3):244-9. PubMed ID: 7976380 [TBL] [Abstract][Full Text] [Related]
32. Structure-function studies of the Na,K-ATPase. Lingrel JB; Van Huysse J; O'Brien W; Jewell-Motz E; Askew R; Schultheis P Kidney Int Suppl; 1994 Jan; 44():S32-9. PubMed ID: 8127032 [TBL] [Abstract][Full Text] [Related]
33. Derivatives of 3-digitoxigenone amidinohydrazone: synthesis and effect on the digitalis receptor of several species. Part 7: Compounds with positive inotropic activity. Heber D; Herzig S; Moosig F; Neujahr H Pharmazie; 1995 Oct; 50(10):663-7. PubMed ID: 7501687 [TBL] [Abstract][Full Text] [Related]
34. [Glycoside receptors of the heart]. Werdan K; Erdmann E Fortschr Med; 1988 Mar; 106(7):135-9. PubMed ID: 2836282 [No Abstract] [Full Text] [Related]
35. Effect of cardiac glycosides on action potential characteristics and contractility in cat ventricular myocytes: role of calcium overload. Ruch SR; Nishio M; Wasserstrom JA J Pharmacol Exp Ther; 2003 Oct; 307(1):419-28. PubMed ID: 12954807 [TBL] [Abstract][Full Text] [Related]
36. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure. Erdmann E; Schwinger R; Böhm M J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118 [TBL] [Abstract][Full Text] [Related]
37. Relationship between cardiotonic effects and inhibition on cardiac sarcolemmal Na+,K+-ATPase of strophan-thidin at low concentrations. Su SW; Wang YL; Li JX; Mei HS; Yin JX Acta Pharmacol Sin; 2003 Nov; 24(11):1103-7. PubMed ID: 14627493 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of Na+,K(+)-ATPase by flavonoids and their inotropic effect. Investigation of the structure-activity relationship. Umarova FT; Khushbactova ZA; Batirov EH; Mekler VM Membr Cell Biol; 1998; 12(1):27-40. PubMed ID: 9829256 [TBL] [Abstract][Full Text] [Related]
39. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking. Wang L; Wible BA; Wan X; Ficker E J Pharmacol Exp Ther; 2007 Feb; 320(2):525-34. PubMed ID: 17095614 [TBL] [Abstract][Full Text] [Related]
40. Effects of Panax notoginseng saponins on myocardial adenosinetriphosphatase. Chen JQ; Zhang YG; Li SL; Zeng Q; Rong MZ Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):347-50. PubMed ID: 7801779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]